Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
about
Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine.Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers.Genetic variations of the xenoreceptors NR1I2 and NR1I3 and their effect on drug disposition and response variability.
P2860
Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
@en
Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
@nl
type
label
Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
@en
Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
@nl
prefLabel
Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
@en
Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
@nl
P2093
P2860
P50
P1476
Population pharmacokinetic study of memantine: effects of clinical and genetic factors.
@en
P2093
Abdel-Messieh Alnawaqil
Agnès Michon
Armin von Gunten
Karsten Ebbing
Laurence Wilhelm
Muriel Noetzli
Serge Zumbach
Sophie Maurer
Valérie Thomazic
P2860
P2888
P304
P356
10.1007/S40262-013-0032-2
P577
2013-03-01T00:00:00Z
P5875
P6179
1047015988